Hope for ALS: new drug enters final testing phase
NCT ID NCT07322003
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests whether the drug pridopidine can slow the progression of ALS, a serious nerve disease. About 500 adults with early-stage ALS will take either pridopidine or a placebo daily for 48 weeks, then all will receive pridopidine for another 48 weeks. Researchers will measure changes in muscle function and survival to see if the drug helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genge Partners
RECRUITINGMontreal, Quebec, H4P 2N2, Canada
Contact Email: •••••@•••••
-
Sean M. Healey & AMG Center for ALS
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Somnos Clinical Research
RECRUITINGLincoln, Nebraska, 68506, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Texas Neurology
RECRUITINGDallas, Texas, 75206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas
RECRUITINGFairway, Kansas, 66205, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.